Saitama, Japan

Takenobu Katagiri

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Saitama Medical University. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takenobu Katagiri. Retrieved from https://idiyas.com/inventor/takenobu-katagiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Takenobu Katagiri

Introduction

Takenobu Katagiri is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ectopic ossification and brain tumors. With a total of four patents to his name, Katagiri's work is recognized for its potential impact on medical treatments.

Latest Patents

One of his latest patents is a method of treating ectopic ossification or diffuse intrinsic pontine glioma in a subject by administering an anti-ALK2 antibody. This application relates to a pharmaceutical composition designed to treat and prevent conditions in patients with an active mutation in the ALK2 protein. The composition includes an anti-ALK2 antibody that binds to ALK2, cross-links it, and inhibits BMP signal transduction. Another significant patent involves an anti-ALK2 antibody that specifically binds to the ALK2 protein and inhibits BMP signal transduction mediated by ALK2. This patent also outlines a method for producing the antibody and a pharmaceutical composition for treating various conditions, including ectopic ossification and diffuse intrinsic pontine glioma.

Career Highlights

Throughout his career, Takenobu Katagiri has worked with esteemed institutions such as Saitama Medical University and Daiichi Sankyo Company, Limited. His research and innovations have contributed to advancements in medical science, particularly in the development of targeted therapies.

Collaborations

Some of his notable coworkers include Sho Tsukamoto and Shinnosuke Tsuji. Their collaborative efforts have further enhanced the research and development of innovative treatments in their field.

Conclusion

Takenobu Katagiri's contributions to medical innovation through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of complex medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…